Your browser doesn't support javascript.
loading
Drug reaction with eosinophilia and systemic symptoms (DRESS) and its relation with autoimmunity in a reference center in Mexico
Matta, Juan Manuel Ruiz; Flores, Silvia Méndez; Cherit, Judith Domínguez.
  • Matta, Juan Manuel Ruiz; Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán. Dermatology Department. Mexico Distrito Federal. MX
  • Flores, Silvia Méndez; Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán. Dermatology Department. Mexico Distrito Federal. MX
  • Cherit, Judith Domínguez; Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán. Dermatology Department. Mexico Distrito Federal. MX
An. bras. dermatol ; 92(1): 30-33, Jan.-Feb. 2017. tab
Article in English | LILACS | ID: biblio-838023
ABSTRACT
Abstract

BACKGROUND:

Drug reaction with eosinophilia and systemic symptoms is a severe adverse drug reaction, with a reported mortality of 10%. Long-term outcomes involve organic failure and autoimmune diseases in some populations.

OBJECTIVE:

To evaluate the clinical prognosis of patients with drug reaction with eosinophilia and systemic symptoms.

METHODS:

We conducted a retrospective review at a referral hospital in Mexico City in a period of 22 years (1992-2013), looking up for records with diagnosis of DRESS according to RegiSCAR criteria. Clinical characteristics, organ failures, culprit drugs, treatment, and short and long-term sequelae were analyzed.

RESULTS:

We found 11 patients with diagnosis of drug reaction with eosinophilia and systemic symptoms syndrome, 7 female and 4 male, with a median age of 22 years-old; 9 had maculopapular rash and 2 were erythrodermic. Affected organs were liver (8/11), kidney (6/11) and hematologic disorders (8/11). The most common culprit drugs were antiepileptic (63%). Systemic corticosteroids were given to 8 patients, being pyelonephritis (1/8) and pneumonia (2/8) the adverse events of this therapy. Long-term sequelae were 1 patient with renal failure, 1 patient with chronic anemia; and 2 patients developed autoimmune diseases (one autoimmune thyroid disease and another one with autoimmune thyroid disease and autoimmune hemolytic anemia). Study

limitations:

The retrospective nature of the study and the limited number of patients with drug reaction with eosinophilia and systemic symptoms.

CONCLUSIONS:

Drug reaction with eosinophilia and systemic symptoms syndrome has been linked to the development of chronic organ failure. We found two young patients who developed autoimmune diseases in the short term. Patients with drug reaction with eosinophilia and systemic symptoms should have a long-term monitoring for signs or symptoms suggestive of an autoimmune disease.
Subject(s)


Full text: Available Index: LILACS (Americas) Main subject: Autoimmune Diseases / Drug Hypersensitivity Syndrome Type of study: Diagnostic study / Observational study / Prognostic study Limits: Adolescent / Adult / Female / Humans / Male Country/Region as subject: Mexico Language: English Journal: An. bras. dermatol Journal subject: Dermatology Year: 2017 Type: Article Affiliation country: Mexico Institution/Affiliation country: Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán/MX

Similar

MEDLINE

...
LILACS

LIS


Full text: Available Index: LILACS (Americas) Main subject: Autoimmune Diseases / Drug Hypersensitivity Syndrome Type of study: Diagnostic study / Observational study / Prognostic study Limits: Adolescent / Adult / Female / Humans / Male Country/Region as subject: Mexico Language: English Journal: An. bras. dermatol Journal subject: Dermatology Year: 2017 Type: Article Affiliation country: Mexico Institution/Affiliation country: Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán/MX